Business
Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
REDWOOD CITY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for the quarter ended March 31, 2026. Recent Highlights Achieved revenue of $2.8 million in the first quarter of 2026Achieved a doubling of independent publications year-over-year to 84 total, accelerating third-party validation of Seer’s platformSecured a collaboration with Precision H
About this update from Seer, Inc.
[{"type":"image","alt":"Seer, Inc.","displaySize":"","headline":null,"caption":"Seer, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":95,"url":"https://media.zenfs.com/en/globenewswire.com/54cda3f3cc4c5a0012780bcda6451a0b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/KAzr34r.34V3qwddJvNZmA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzMw--/https://media.zenfs.com/en/globenewswire.com/54cda3f3cc4c5a0012780bcda6451a0b","width":300,"height":95},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/KAzr34r.34V3qwddJvNZmA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzMw--/https://media.zenfs.com/en/globenewswire.com/54cda3f3cc4c5a0012780bcda6451a0b","width":300,"height":95}},"lazy":false},{"type":"text","content":"REDWOOD CITY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for the quarter ended March 31, 2026.","length":250,"tagName":"p"},{"type":"text","content":"Recent Highlights ","length":17,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Achieved revenue of $2.8 million in the first quarter of 2026","length":61,"tagName":"p"}]},{"val":[{"type":"text","content":"Achieved a doubling of independent publications year-over-year to 84 total, accelerating third-party validation of Seer’s platform","length":130,"tagName":"p"}]},{"val":[{"type":"text","content":"Secured a collaboration with Precision Health Research, Singapore to provide deep, unbiased proteomics on 10,000 samples for their PRECISE-SG100K study, a landmark multi-ancestry, population-scale cohort of approximately 100,000 Singapore residents","length":248,"tagName":"p"}]},{"val":[{"type":"text","content":"Strengthened the leadership team with the appointment of Anthony (Tony) Bazarko as Chief Commercial Officer, bringing deep expertise to drive strategy, partnerships, and market adoption.","length":186,"tagName":"p"}]},{"val":[{"type":"text","content":"Successfully defended and reinforced Seer's IP position through a U.S. Patent and Trademark Office Final Written Decision","length":125,"tagName":"p"}]},{"val":[{"type":"text","content":"Repurchased approximately 1.5 million Class A common shares under our share repurchase program authorization","length":108,"tagName":"p"}]},{"val":[{"type...